☆ 4.4 Review

Photoactivated chromophore-corneal cross-linking accelerates corneal healing in fungal keratitis: an updated meta-analysis

SYSTEMATIC REVIEWS (2023)

Related references

Note: Only part of the references are listed.

Article Ophthalmology

The epidemiology of infectious keratitis

Fiona Stapleton

Summary: Infectious keratitis is a rare but potentially severe disease that can lead to vision loss. Its incidence, risk factors, and impact vary widely according to region, healthcare access, socioeconomic and environmental factors, predisposing conditions, and causing organisms. Low-income countries have a higher frequency and societal impact of infectious keratitis, and bacterial causes are more common in most regions. Fungi, especially related to agricultural trauma, are more frequently associated with infectious keratitis in low-income regions, particularly in India and certain African countries. Early diagnosis, appropriate treatment, prophylaxis in ocular trauma, eye protection, and awareness of risk factors may reduce disease severity and vision loss. However, more research is needed in certain regions to identify independent risk factors and guide preventative strategies.

OCULAR SURFACE (2023)

Add to Collection

Article Ophthalmology

Mediators of the Effect of Corneal Cross-Linking on Visual Acuity for Fungal Ulcers

N. Venkatesh Prajna et al.

CORNEA (2022)

Add to Collection

Article Ophthalmology

PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial

Farhad Hafezi et al.

Summary: This study demonstrates that standalone photoactivated chromophore corneal cross-linking (PACK-CXL) may be an effective first-line treatment for early to moderate infectious keratitis, with similar cure rates compared to standard antimicrobial therapy. This is significant for one of the major causes of global blindness, infectious keratitis.

EYE AND VISION (2022)

Add to Collection

Review Ophthalmology

Infectious keratitis: A review

Maria Cabrera-Aguas et al.

Summary: Infectious keratitis is the fifth leading cause of blindness globally. Contact lens wear, ocular injury, and ocular surface disease are the main predisposing factors. Staphylococcus species, Pseudomonas aeruginosa, Fusarium species, Candida species, and Acanthamoeba species are the most common causal organisms. Culture, PCR, and in vivo confocal microscopy are used to diagnose the infection. Empiric therapy depends on the type of keratitis. Delayed diagnosis and inappropriate antimicrobial therapy can lead to vision impairment, blindness, and even loss of the eye.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)

Add to Collection

Article Ophthalmology

Therapeutic Effect of Corneal Crosslinking on Fungal Keratitis: Efficacy of Corneal Collagen Crosslinking as an Adjuvant Therapy for Fungal Keratitis in a Tertiary Eye Hospital in South India

Vimalin Jeyalatha Mani et al.

Summary: This study evaluated the efficacy of corneal collagen crosslinking as an adjuvant therapy for fungal keratitis. The results showed that the group receiving CXL in combination with standard antifungal treatment had a significantly shorter time for ulcer resolution, improved final best-corrected visual acuity, and significant changes in cytokine expression.

OCULAR IMMUNOLOGY AND INFLAMMATION (2021)

Add to Collection

Article Ophthalmology

Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis

N. Venkatesh Prajna et al.

Summary: Through a randomized controlled clinical trial, the authors found that adjuvant corneal cross-linking (CXL) did not show significant benefits in the primary treatment of bacterial keratitis. However, CXL may reduce culture positivity and complication rates.

CORNEA (2021)

Add to Collection

Review Ophthalmology

Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance

Darren Shu Jeng Ting et al.

Summary: Corneal opacity is the 5th leading cause of blindness globally, and infectious keratitis (IK) is the main cause of corneal blindness in both developed and developing countries. Bacteria and fungi are the most common causative microorganisms, with major risk factors including contact lens wear and ocular surface diseases. Broad-spectrum topical antimicrobial treatment is the mainstay of treatment for IK, although antimicrobial resistance poses a challenge in some parts of the world.

EYE (2021)

Add to Collection

Review Microbiology

Recent Perspectives in the Management of Fungal Keratitis

Nimmy Raj et al.

Summary: Mycotic keratitis is common in warm and humid regions with various pathogenic fungi profiles. Fungal hyphae and culture isolation are standard for laboratory diagnosis, but newer investigative modalities like in vivo confocal microscopy and molecular diagnostics are gaining popularity. Molecular techniques now provide rapid diagnosis of fungal keratitis.

JOURNAL OF FUNGI (2021)

Add to Collection

Review Microbiology

Mycotic Keratitis-A Global Threat from the Filamentous Fungi

Jeremy J. Hoffman et al.

Summary: Mycotic or fungal keratitis is a sight-threatening disease caused by infection of the cornea by filamentous fungi or yeasts. In tropical and some low-income countries, it accounts for the majority of cases of microbial keratitis. Trauma with organic plant-based material is the predominant risk factor for filamentous fungal keratitis.

JOURNAL OF FUNGI (2021)

Add to Collection

Article Ophthalmology

Cross-Linking-Assisted Infection Reduction A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis

N. Venkatesh Prajna et al.

OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

High Fluence Increases the Antibacterial Efficacy of PACK Cross-Linking

Sabine Kling et al.

CORNEA (2020)

Add to Collection

Article Ophthalmology

Cross-Linking Assisted Infection Reduction (CLAIR): One-year Follow-up from a Randomized Clinical Trial Evaluating Adjuvant Cross-Linking in the Treatment of Fungal Keratitis

N.V. Prajna et al.

OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

Corneal Cross-linking as an Adjunct for The Management of Refractory Fungal Keratitis

Shahram Bamdad et al.

MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY (2020)

Add to Collection

Review Ophthalmology

Collagen Cross-Linking in the Management of Microbial Keratitis

Chiara Bonzano et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2019)

Add to Collection

Review Ophthalmology

Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis

Darren Shu Jeng Ting et al.

OCULAR SURFACE (2019)

Add to Collection

Article Ophthalmology

Accelerated Corneal Cross-Linking With Photoactivated Chromophore for Moderate Therapy-Resistant Infectious Keratitis

Boris Knyazer et al.

CORNEA (2018)

Add to Collection

Article Ophthalmology

PACK-CXL in Reducing the Time to Heal in Suppurative Corneal Ulcers: Observations of a Pilot Study From South India

Priya Basaiawmoit et al.

CORNEA (2018)

Add to Collection

Article Ophthalmology

Effect of Riboflavin/Rose Bengal-Mediated PACK-CXL on Acanthamoeba Trophozoites and Cysts in Vitro

Hatice Tuba Atalay et al.

CURRENT EYE RESEARCH (2018)

Add to Collection

Article Mycology

Corneal Collagen Cross-Linking for the Management of Mycotic Keratitis

Elif Erdem et al.

MYCOPATHOLOGIA (2018)

Add to Collection

Letter Ophthalmology

Photoactivated Chromophore for Moderate to Severe Infectious Keratitis as an Adjunct Therapy: A Randomized Controlled Trial

Farhad Hafezi et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Photoactivated Chromophore for Moderate to Severe Infectious Keratitis as an Adjunct Therapy: A Randomized Controlled Trial

Ngamjit Kasetsuwan et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis

Lamprini Papaioannou et al.

CORNEA (2016)

Add to Collection

Article Ophthalmology

Ultraviolet A/Riboflavin Collagen Cross-Linking for Treatment of Moderate Bacterial Corneal Ulcers

Shahram Bamdad et al.

CORNEA (2015)

Add to Collection

Article Ophthalmology

Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis

Rasik B. Vajpayee et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)

Add to Collection

Editorial Material Ophthalmology

PACK-CXL: Defining CXL for Infectious Keratitis

Farhad Hafezi et al.

JOURNAL OF REFRACTIVE SURGERY (2014)

Add to Collection

Article Ophthalmology

Antibacterial Efficacy of Accelerated Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-linking (PACK-CXL)

Olivier Richoz et al.

JOURNAL OF REFRACTIVE SURGERY (2014)

Add to Collection

Article Ophthalmology

Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting

Dalia G. Said et al.

OPHTHALMOLOGY (2014)

Add to Collection

Article Ophthalmology

Cross-linking for microbial keratitis

Jayesh Vazirani et al.

INDIAN JOURNAL OF OPHTHALMOLOGY (2013)

Add to Collection

Review Ophthalmology

Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases

Jorge L. Alio et al.

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2013)

Add to Collection

Review Critical Care Medicine

Lack of Efficacy of Probiotics in Preventing Ventilator-Associated Pneumonia A Systematic Review and Meta-analysis of Randomized Controlled Trials

Wan-Jie Gu et al.

CHEST (2012)

Add to Collection

Article Ophthalmology

UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study

Karim Makdoumi et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)

Add to Collection

Article Ophthalmology

Photoactivated Riboflavin Treatment of Infectious Keratitis Using Collagen Cross-linking Technology

Marianne O. Price et al.

JOURNAL OF REFRACTIVE SURGERY (2012)

Add to Collection

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Add to Collection

Article Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Editorial Material Medicine, General & Internal

GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon H. Guyatt et al.

BRITISH MEDICAL JOURNAL (2008)

Add to Collection

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.